Glucometabolic control of once-weekly dulaglutide switched from DPP4 inhibitor versus daily empagliflozin add-on in patients with type 2 diabetes inadequately controlled with metformin, sulfonylurea, and DPP4 inhibitor: A randomised trial
| Autor: | Lee, Eun Young, Cho, Jae-Hyoung, Lee, Woo Je, Kim, Nam Hoon, Kim, Jae Hyeon, Lee, Byung-Wan |
|---|---|
| Zdroj: | In Diabetes Research and Clinical Practice September 2023 203 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect